1. Home
  2. OVID vs SRL Comparison

OVID vs SRL Comparison

Compare OVID & SRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • SRL
  • Stock Information
  • Founded
  • OVID 2014
  • SRL 2017
  • Country
  • OVID United States
  • SRL China
  • Employees
  • OVID N/A
  • SRL N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • SRL Professional Services
  • Sector
  • OVID Health Care
  • SRL Consumer Discretionary
  • Exchange
  • OVID Nasdaq
  • SRL Nasdaq
  • Market Cap
  • OVID 88.9M
  • SRL 81.5M
  • IPO Year
  • OVID 2017
  • SRL N/A
  • Fundamental
  • Price
  • OVID $1.72
  • SRL N/A
  • Analyst Decision
  • OVID Strong Buy
  • SRL
  • Analyst Count
  • OVID 4
  • SRL 0
  • Target Price
  • OVID $3.13
  • SRL N/A
  • AVG Volume (30 Days)
  • OVID 5.1M
  • SRL 8.4K
  • Earning Date
  • OVID 11-11-2025
  • SRL 04-30-2025
  • Dividend Yield
  • OVID N/A
  • SRL 18.91%
  • EPS Growth
  • OVID N/A
  • SRL N/A
  • EPS
  • OVID N/A
  • SRL N/A
  • Revenue
  • OVID $6,651,000.00
  • SRL $24,535,042.00
  • Revenue This Year
  • OVID $1,086.57
  • SRL N/A
  • Revenue Next Year
  • OVID N/A
  • SRL N/A
  • P/E Ratio
  • OVID N/A
  • SRL N/A
  • Revenue Growth
  • OVID 1070.95
  • SRL N/A
  • 52 Week Low
  • OVID $0.24
  • SRL $5.13
  • 52 Week High
  • OVID $2.01
  • SRL $9.99
  • Technical
  • Relative Strength Index (RSI)
  • OVID 63.50
  • SRL 46.42
  • Support Level
  • OVID $1.24
  • SRL $5.48
  • Resistance Level
  • OVID $2.01
  • SRL $6.00
  • Average True Range (ATR)
  • OVID 0.20
  • SRL 0.44
  • MACD
  • OVID 0.03
  • SRL -0.02
  • Stochastic Oscillator
  • OVID 66.29
  • SRL 10.67

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About SRL Scully Royalty Ltd.

Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.

Share on Social Networks: